Healthcare Services

Global Catheter-Related Bloodstream Infection Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Catheter-Related Bloodstream Infection Market In 2026 And What Value Is Projected For 2030?

The catheter-related bloodstream infection market size has demonstrated robust expansion in recent years. It is anticipated to expand from $1.62 billion in 2025 to $1.71 billion in 2026, registering a compound annual growth rate (CAGR) of 6.0%. This historical growth can be attributed to factors such as the increased deployment of central venous catheters, a rising occurrence of hospital-acquired infections, the adoption of antibiotic lock therapy, the expansion of intensive care units, and enhanced clinical awareness of CRBSI.

The catheter-related bloodstream infection market size is projected to experience robust expansion over the upcoming years. This market is anticipated to reach $2.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This expansion during the projection period stems from heightened investments in protocols for infection prevention, an escalating need for antimicrobial resistance management, the broadening of hospital infection control initiatives, increasing embrace of combination therapies, and innovations in diagnostic technologies. Key trends anticipated within the forecast timeframe encompass the wider application of sophisticated antimicrobial lock solutions, the expanding implementation of infection surveillance programs, a heightened emphasis on preventing hospital-acquired infections, the proliferation of combination antimicrobial therapies, and a greater focus on timely diagnosis and intervention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp

What Drivers Are Influencing The Catheter-Related Bloodstream Infection Market?

The expanding incidence of hospital-acquired infections is anticipated to boost the catheter-related bloodstream infection market in the coming years. Hospital-acquired infections (HAIs) are infections contracted by patients during medical treatment in a healthcare environment, typically appearing at least 48 hours post-admission. The rise in these infections stems from factors like antimicrobial resistance, insufficient infection control protocols, and patient vulnerability. Catheter-related bloodstream infections significantly contribute to HAIs because they are invasive and prone to microbial growth, endangering individuals with implanted catheters. For example, data from September 2025, cited by the US-based National Library of Medicine, indicated that in 2024, antimicrobial-resistant organisms (AROs) constituted 6.6% of infections. Additionally, approximately one-third of healthcare-associated infections (HAIs) were associated with medical devices, and central line-associated bloodstream infections (CLABSIs) saw their prevalence double to 0.4%. Consequently, the growing frequency of hospital-acquired infections will fuel the expansion of the catheter-related bloodstream infection market.

What Are The Key Segments Of The Catheter-Related Bloodstream Infection Market?

The catheter-related bloodstream infection market covered in this report is segmented –

1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents

2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies

Subsegments:

1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy

2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents

What Industry Trends Are Redefining The Catheter-Related Bloodstream Infection Market?

Leading companies in the catheter-related bloodstream infection market are creating advanced catheter lock solutions to improve infection prevention and patient results. A catheter lock solution is a fluid inserted into a catheter to deter infections and keep the catheter open between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical company concentrating on the development and commercialization of therapeutic products, obtained US Food and Drug Administration approval for DefenCath (taurolidine and heparin) catheter lock solution, designed for adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). This antimicrobial and antifungal solution is specifically engineered to lessen catheter-related bloodstream infections (CRBSIs), by merging heparin for anticoagulation with taurolidine’s extensive antimicrobial qualities.

Who Are The Leading Companies Operating In The Catheter-Related Bloodstream Infection Market?

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

Read the full catheter-related bloodstream infection market report here:

https://www.thebusinessresearchcompany.com/report/catheter-related-bloodstream-infection-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Catheter-Related Bloodstream Infection Market?

North America was the largest region in the catheter-related bloodstream infection market in 2025. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Catheter-Related Bloodstream Infection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp

Browse Through More Reports Similar to the Global Catheter-Related Bloodstream Infection Market 2026, By The Business Research Company

Phospholipid Global Market Report

https://www.thebusinessresearchcompany.com/report/phospholipid-global-market-report

Lecithin And Phospholipids Global Market Report

https://www.thebusinessresearchcompany.com/report/lecithin-and-phospholipids-global-market-report

Hypolipidemics Global Market Report

https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795